Discontinued — last reported Q4 '22

Other

Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount

Insmed Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount remained flat by 0.0% to $82.85M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 49.8%, from $55.33M to $82.85M. Over 4 years (FY 2021 to FY 2025), Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount shows an upward trend with a 43.8% CAGR. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementIncome Statement
SectionOther
CategoryRisk
SignalLower is better
VolatilityModerate
First reportedQ1 2015
Last reportedQ4 2022

How to read this metric

An increase suggests management expects lower future taxable income or increased uncertainty regarding tax asset realization, while a decrease signals improved tax planning or higher expected future earnings.

Detailed definition

Represents the net change in the valuation allowance established against deferred tax assets. This allowance is recorded...

Peer comparison

Standard tax accounting metric found in the income tax footnote of most large public corporations.

Metric ID: other_valuation_allowance_deferred_tax_asset_change_in_amount

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$77.60M$157.70M-$158.90M$221.30M$331.40M
YoY Change—+103.2%-200.8%+239.3%+49.8%
Range-$158.90M – $331.40M
CAGR+43.8%
Avg YoY Growth+47.9%
Median YoY Growth+76.5%
Current Streak2 years growth

Frequently Asked Questions

What is Insmed's valuation allowance, deferred tax asset, increase (decrease), amount?
Insmed (INSM) reported valuation allowance, deferred tax asset, increase (decrease), amount of $82.85M in Q4 2025.
How has Insmed's valuation allowance, deferred tax asset, increase (decrease), amount changed year-over-year?
Insmed's valuation allowance, deferred tax asset, increase (decrease), amount increased by 49.8% year-over-year, from $55.33M to $82.85M.
What is the long-term trend for Insmed's valuation allowance, deferred tax asset, increase (decrease), amount?
Over 4 years (2021 to 2025), Insmed's valuation allowance, deferred tax asset, increase (decrease), amount has grown at a 43.8% compound annual growth rate (CAGR), from $77.60M to $331.40M.
What does valuation allowance, deferred tax asset, increase (decrease), amount mean?
The change in the reserve set aside for deferred tax assets that may not be realized.